scholarly journals Risk associated with central catheters for malignant tumor patients: a systematic review and meta-analysis

Oncotarget ◽  
2018 ◽  
Vol 9 (15) ◽  
pp. 12376-12388 ◽  
Author(s):  
Yajuan Lv ◽  
Yong Hou ◽  
Bo Pan ◽  
Yuwan Ma ◽  
Paiyun Li ◽  
...  
2019 ◽  
Vol 220 (1) ◽  
pp. S542-S543
Author(s):  
Antonina I. Frolova ◽  
Matthew A. Shanahan ◽  
Metthodius G. Tuuli ◽  
Laura E. Simon ◽  
Omar M. Young

The Lancet ◽  
2013 ◽  
Vol 382 (9889) ◽  
pp. 311-325 ◽  
Author(s):  
Vineet Chopra ◽  
Sarah Anand ◽  
Andy Hickner ◽  
Michael Buist ◽  
Mary AM Rogers ◽  
...  

2016 ◽  
Vol 9 (1) ◽  
pp. 32-40 ◽  
Author(s):  
Ran Chen ◽  
Pei-Chun Peng ◽  
Bin Wen ◽  
Fu-Ying Li ◽  
Sheng Xie ◽  
...  

2017 ◽  
Vol 18 (4) ◽  
pp. 273-278 ◽  
Author(s):  
Filippo Sanfilippo ◽  
Alberto Noto ◽  
Gennaro Martucci ◽  
Marco Farbo ◽  
Gaetano Burgio ◽  
...  

Introduction The central venous pressure (CVP) is the most commonly used static marker of preload for guiding fluid therapy in critically ill patients, though its usefulness remains controversial. Centrally inserted central catheters (CICCs) are the gold-standard devices for CVP monitoring but peripherally inserted central catheters (PICCs) may represent a valid alternative. We undertook a systematic review and meta-analysis with the aim to investigate whether the difference between PICC- and CICC-measured CVP is not significant. Methods We searched for clinical studies published in PubMed and EMBASE databases from inception until December 21st 2016. We included studies providing data on paired and simultaneous CVP measurement from PICCs and CICCs. We conducted two analyses on the values of CVP, the first one according to the total number of CVP assessments, the second one considering the number of patients recruited. Results Four studies matched the inclusion criteria, but only three of them provided data for the meta-analyses. Both analyses showed non-significant differences between PICC-measured and CICC-measured CVP: 1489 paired simultaneous CVP assessments (MD 0.16, 95%CI −0.14, 0.45, p = 0.30) on a total of 57 patients (MD 0.22, 95%CI −1.46, 1.91, p = 0.80). Both analyses showed no heterogeneity (I2 = 0%). Conclusions Available evidence supports that CVP monitoring with PICCs is accurate and reproduces similar values to those obtained from CICCs. The possibility to monitor CVP should not be used among clinical criteria for preferring a CICC over a PICC line.


Sign in / Sign up

Export Citation Format

Share Document